Cambium Bio Ltd (CMB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.444x

Based on the latest financial reports, Cambium Bio Ltd (CMB) has a cash flow conversion efficiency ratio of -1.444x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.65 Million ≈ $-1.88 Million USD) by net assets (AU$1.84 Million ≈ $1.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cambium Bio Ltd net asset quality index to measure how much of total assets are equity-financed.

Cambium Bio Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Cambium Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CMB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Cambium Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cambium Bio Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Morgan Advanced Materials plc LSE:MGAM	0.133x
Tourn International AB ST:TOURN	0.052x
Finexia Financial Group Ltd AU:FNX	-0.436x
FBS Global Limited Ordinary Shares NASDAQ:FBGL	N/A
HWH International Inc NASDAQ:HWH	-0.381x
XOX Bhd KLSE:0165	0.194x
paragon GmbH & Co. KGaA F:PGN	0.013x
IMAGIS Co. Ltd KQ:115610	0.146x

Annual Cash Flow Conversion Efficiency for Cambium Bio Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Cambium Bio Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see CMB market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-5.24 Million ≈ $-3.71 Million	-2.856x	-4986.40%
2024-06-30	AU$2.78 Million ≈ $1.96 Million	AU$-155.86K ≈ $-110.28K	-0.056x	-116.58%
2023-06-30	AU$-1.95 Million ≈ $-1.38 Million	AU$-660.46K ≈ $-467.32K	0.339x	+110.13%
2022-06-30	AU$1.07 Million ≈ $760.48K	AU$-3.59 Million ≈ $-2.54 Million	-3.341x	-672.70%
2021-06-30	AU$4.15 Million ≈ $2.93 Million	AU$2.42 Million ≈ $1.71 Million	0.583x	+132.85%
2020-06-30	AU$1.09 Million ≈ $774.10K	AU$-1.94 Million ≈ $-1.37 Million	-1.776x	-414.34%
2019-06-30	AU$-6.39 Million ≈ $-4.52 Million	AU$-3.61 Million ≈ $-2.55 Million	0.565x	+138.87%
2018-06-30	AU$2.92 Million ≈ $2.07 Million	AU$-4.25 Million ≈ $-3.01 Million	-1.454x	-428.22%
2017-06-30	AU$8.10 Million ≈ $5.73 Million	AU$3.59 Million ≈ $2.54 Million	0.443x	+194.04%
2016-06-30	AU$4.78 Million ≈ $3.39 Million	AU$-2.25 Million ≈ $-1.59 Million	-0.471x	+34.23%
2015-06-30	AU$8.27 Million ≈ $5.85 Million	AU$-5.92 Million ≈ $-4.19 Million	-0.716x	+4.65%
2014-06-30	AU$8.31 Million ≈ $5.88 Million	AU$-6.24 Million ≈ $-4.41 Million	-0.751x	-146.66%
2013-06-30	AU$-2.87 Million ≈ $-2.03 Million	AU$-4.62 Million ≈ $-3.27 Million	1.610x	+206.69%
2012-06-30	AU$1.95 Million ≈ $1.38 Million	AU$-2.94 Million ≈ $-2.08 Million	-1.509x	-372.04%
2011-06-30	AU$3.29 Million ≈ $2.33 Million	AU$-1.05 Million ≈ $-743.44K	-0.320x	-338.79%
2002-06-30	AU$40.54 Million ≈ $28.68 Million	AU$5.43 Million ≈ $3.84 Million	0.134x	-31.25%
2001-06-30	AU$196.21 Million ≈ $138.83 Million	AU$38.20 Million ≈ $27.03 Million	0.195x	-35.02%
2000-06-30	AU$161.09 Million ≈ $113.98 Million	AU$48.26 Million ≈ $34.15 Million	0.300x	+17.02%
1999-06-30	AU$130.56 Million ≈ $92.38 Million	AU$33.43 Million ≈ $23.65 Million	0.256x	--

About Cambium Bio Ltd

AU:CMB Australia Biotechnology

Market Cap

$7.93 Million

AU$11.21 Million AUD

Market Cap Rank

#27607 Global

#1371 in Australia

Share Price

AU$0.41

Change (1 day)

-4.65%

52-Week Range

AU$0.35 - AU$0.60

All Time High

AU$22.97